about
Ebola virus diseaseRisk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic reviewShort and long-term safety of the 2009 AS03-adjuvanted pandemic vaccinePrediction tools for unfavourable outcomes in Clostridium difficile infection: a systematic reviewTransmission of acute gastroenteritis and respiratory illness from children to parents.A microbiological explanation for the obesity pandemic?Corticosteroid therapy in critical illness due to seasonal and pandemic influenzaAccuracy and generalizability of using automated methods for identifying adverse events from electronic health record data: a validation study protocol.Rationale for and protocol of a multi-national population-based bacteremia surveillance collaborativeSalmonella enterica bacteraemia: a multi-national population-based cohort studyFinancial impact of health care-associated infections: When money talksEvolution of the global burden of viral infections from unsafe medical injections, 2000-2010.Current trends in nontuberculous mycobacteria infections in Canadian children: A pediatric investigators collaborative network on infections in Canada (PICNIC) studyMortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in QuebecThe cellulitis season is open.Bill C-442: Shining the limelight on the Lyme-like?Effects of lifestyle interventions that include a physical activity component in class II and III obese individuals: a systematic review and meta-analysis.Antimicrobial shortages: Another hurdle for cliniciansClostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.Get shorty!Impact of methicillin resistant Staphylococcus aureus contact isolation units on medical careFidaxomicin versus Vancomycin in the Treatment of Clostridium difficile Infection: Canadian OutcomesCombination of Heat Shock and Enhanced Thermal Regime to Control the Growth of a Persistent Legionella pneumophila StrainBurden of Clostridium difficile Infections in Québec by Levy et al.Burden of rotavirus disease: A population-based study in Eastern Townships, Quebec.Energy Conservation and the Promotion of Legionella pneumophila Growth: The Probable Role of Heat Exchangers in a Nosocomial Outbreak.Management of severe infections: A time to keep a cool head or a hot topic for clinical trials?Mycobacterium tuberculosis: 2014 Clinical trials in reviewBurden of vaccine-preventable pneumococcal disease in hospitalized adults: A Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) network study.Sustained impact of a computer-assisted antimicrobial stewardship intervention on antimicrobial use and length of stay.Lack of association between clinical outcome of Clostridium difficile infections, strain type, and virulence-associated phenotypes.Epidemiology of Haemophilus influenzae bacteremia: a multi-national population-based assessment.Outpatient parenteral antimicrobial therapy.Bezlotoxumab for the prevention of Clostridium difficile recurrence.The changing epidemiology of group B streptococcus bloodstream infection: a multi-national population-based assessment.Laboratory diagnosis of Ebola virus disease.Prediction of complicated Clostridium difficile infection by pleural effusion and increased wall thickness on computed tomography.Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.Efficacy of Secondary Prophylaxis With Vancomycin for Preventing Recurrent Clostridium difficile Infections.Evaluation of a machine learning capability for a clinical decision support system to enhance antimicrobial stewardship programs.
P50
Q24563097-24108D11-6C42-4B66-A54D-441486AB443EQ27021390-3F777488-B55B-4A47-AEE3-0684C404EFDEQ28727578-10AF496C-A939-465F-8330-04A490DB7D98Q28732437-85894C8B-6CFB-490E-BFCA-E01E217C9A47Q30358464-7E65B428-F55E-47D0-A9A9-32A8EA2CCF2AQ30370756-57D65D67-44E6-42A2-9A1B-97522656D101Q30379936-28CAEC3A-AC8B-4455-85B6-981F8CC4ADD4Q31162597-90B65E03-BE17-4649-8044-E94D531EFCABQ33485564-8680833C-BD4E-44F3-9B25-917BC65C88AAQ33557559-6A4AB2B2-D9D9-42CC-B691-FDA9D758B8F3Q33640204-5607C3ED-9CFF-4469-8CEB-26E3D315C7E5Q33727801-CF3ACA5B-B06B-4632-8ED5-6BF79D696A38Q33885874-A1572E87-8BFF-4BDC-9819-59A590663CB6Q34099215-A3BDD780-17FF-4305-83AE-86DAA5C23D44Q34238390-EC84CB7E-2603-4B0B-9C88-2B12CD005278Q34413366-E7E2EA29-689A-4E69-89A5-7EA1DF343B4DQ35242025-A43B4C37-1CF1-46FB-B425-64B9109BB751Q35569872-53E69F50-A7D5-4B5F-A757-349C8780D6BBQ35874779-704E89CD-535F-4B4B-82FD-BEFAA830CB76Q36015646-35E7D4B3-2C47-4796-B875-862A76B5B874Q36636228-C7E2A02C-88DE-4E00-B066-46C47202E23AQ36996876-90D475E8-C8D1-4E5F-B331-59007C703366Q37061397-D0B1C387-D27E-4D91-8AB5-912D665A4663Q37089465-CCB5F330-00F8-4488-AEEC-8E411D53B833Q37366751-A31F2E00-05CE-4BCA-A6DA-CDA518B72CB1Q37542078-D87EEFC5-568E-4CB0-9AB5-3CE4CEED7E45Q38257973-02BE29D6-72E2-42A1-B099-F51F87B305F7Q38387116-179D3C27-8150-4ABF-B9B6-04258F778CAAQ38758330-7CA9298B-C679-488D-BC7F-1EDCB7C6E9F2Q39080561-75C49DD2-D52A-4976-AB19-19AD39DB77C9Q39665226-35F63B9C-0EED-4837-847A-827F6B644490Q39814969-267702C2-9918-4B29-A4DF-6360B71E1AE9Q39938810-4910C2E3-55B6-41E6-A686-DC19D5B95DA8Q40095035-5DF9575D-A06B-4FDD-99EC-0F847F2087CBQ40115733-8F2A9A51-F193-476D-9894-ED54ABB9AB40Q40171703-F3413852-C609-45B8-A5DE-85F4C3E28389Q40384874-B310C961-328D-4069-946E-5B8A0E61C7A9Q40438125-B91E125D-AF8F-4D76-BC03-A6279CF72CCBQ40543183-236033D4-CC93-4E7D-9AA0-53C81D925069Q40766097-26DAA3B7-A847-4BFB-A732-BD15B6897306
P50
name
Louis Valiquette
@ast
Louis Valiquette
@en
Louis Valiquette
@nl
type
label
Louis Valiquette
@ast
Louis Valiquette
@en
Louis Valiquette
@nl
prefLabel
Louis Valiquette
@ast
Louis Valiquette
@en
Louis Valiquette
@nl